ArticleFrontiers in nutrition2025
The ferroform and glycoform landscape of human milk lactoferrin dissected through hybrid mass spectrometric approaches.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Native Multidimensional Protein Complex Identification and Topology Characterization (Native MudPIT).Analytical chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human milk lactoferrin (hmLF), a sialic acid-rich iron-binding milk glycoprotein, is essential for infant development, playing a key role in immune defense and gut maturation. Despite its importance, the diversity of hmLF proteoforms, including the relationship between glycosylation profiles (glycoforms) and iron-binding states (ferroforms), has not been systematically characterized. To address this, we used a hybrid mass spectrometry (MS) approach, combining bottom-up glycoproteomics and ion-exchange (IEX) native MS, to analyze hmLF from three human milk donors across lactation. Bottom-up glycoproteomic results revealed that Asn642 remained predominantly not glycosylated, while Asn156 and Asn497 were frequently occupied with biantennary glycans exhibiting variable fucosylation and sialylation. Notably, glycan heterogeneity displayed a site-specific pattern, decreasing consistently in both donors over lactation. Additionally, we used an IEX-native MS strategy to obtain a full picture of the glyco- and ferroforms coexisting in human milk at late lactation stages. IEX separated LF molecules primarily by iron content rather than glycan composition, resulting in five LF fractions with varying iron-loading and glycosylation levels. Native MS full proteoform profiling of these fractions validated that most LF molecules were glycosylated at two of the three available sites, likely Asn156 and Asn497, yet revealed a minor pool of proteoforms glycosylated at all three sites. Careful evaluation of individual fractions and compiled data revealed no clear correlation between ferroform and
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.